House subcommittee to discuss PDUFA V

The health subcommittee of the U.S. House Energy & Commerce Committee will hold a July 7 hearing on PDUFA V. Witnesses include Janet Woodcock, director of FDA's Center for Drug Evaluation and Research; Paul Hastings, president and CEO of cancer company OncoMed Pharmaceuticals Inc. (Redwood City, Calif.); Jonathan Leff, managing director at Warburg Pincus; Marc Boutin, EVP and COO of the not-for-profit National Health Council; Ellen Sigal, chair and founder of not-for-profit Friends of Cancer Research; and Allan Coukell, director of medical programs for the Pew Health Group unit of not-for-profit The Pew Charitable Trusts. ...